Rivaroxaban als effektive Therapieoption der Livedovaskulopathie
Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung
Beitragende
Abstract
The livedoid vasculopathy is a rare disease caused by thromboembolic occlusion of small and medium vessels in the superficial dermal plexus. Immunosuppressive treatment was often ineffective and resulted in a refractory disease cause. The efficiency of anticoagulants in the treatment of the disease was described a couple of years ago. Here, we report successful treatment with rivaroxaban and fast achievement of remission in a 30-year-old patient with livedoid vasculopathy.
Details
Originalsprache | Deutsch |
---|---|
Seiten (von - bis) | 199-201 |
Seitenumfang | 3 |
Fachzeitschrift | Aktuelle Dermatologie |
Jahrgang | 43 |
Ausgabenummer | 5 |
Publikationsstatus | Veröffentlicht - 1 Mai 2017 |
Peer-Review-Status | Ja |
Externe IDs
ORCID | /0000-0002-8217-6872/work/152545006 |
---|---|
ORCID | /0000-0002-2164-4644/work/152545843 |
ORCID | /0000-0002-4330-1861/work/152544350 |